BERRYLAW advised Delpharm during the acquisition. Delpharm and Dr. Reddy’s announced the completion of Delpharm’s acquisition of the sterile injectable drug development center located in Leiden,...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here